Close Menu

Michael Arrington has a post at the TechCrunch blog about his own experience sending in his DNA to 23andMe. Before you let out a "been there, done that" yawn, GTO has this to say -- Arrington raises a great issue that we haven't seen in anyone else's posts so far. What if, he asks, he just sends in someone else's DNA under his own name? Sure, a service company like 23andMe could easily distinguish male DNA from female.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

In PLOS this week: preconception carrier screening program results, comparative genomics-based analysis of Elizabethkingia meningoseptica, and more.

Canadian regulators are beginning to share information from new drug studies, Undark reports.

In a column at the Dallas Morning News, the Stanley Medical Research Institute's E. Fuller Torrey says the Human Genome Project hasn't delivered on promised results.

Researchers explore a possible genetic cause for some cases of sudden infant death syndrome, KOMO News reports.